15th Nov 2021 20:37
Destiny Pharma PLC - clinical stage biotechnology company based in Brighton, England - Says Non-Executive Director Peter Morgan has decided to step down from the board with effect from March 31, 2022. A search for a replacement is underway.
Current stock price: 122.00 pence
Year-to-date change: up 77%
By Arvind Bhunjun; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
DEST.L